Handelsbanken Fonder AB Sells 3,100 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Handelsbanken Fonder AB decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 8.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 31,800 shares of the company’s stock after selling 3,100 shares during the period. Handelsbanken Fonder AB’s holdings in Henry Schein were worth $2,201,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Versant Capital Management Inc boosted its stake in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC boosted its stake in Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares during the period. Quent Capital LLC boosted its stake in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares during the period. City State Bank bought a new stake in Henry Schein during the fourth quarter valued at $55,000. Finally, Farther Finance Advisors LLC boosted its stake in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the period. Institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on HSIC shares. Barrington Research lifted their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th. Wells Fargo & Company started coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $80.09.

Henry Schein Stock Up 0.5 %

HSIC opened at $77.64 on Tuesday. The company has a market cap of $9.68 billion, a P/E ratio of 31.95, a P/E/G ratio of 2.13 and a beta of 0.91. The business’s 50-day moving average price is $74.19 and its 200-day moving average price is $72.38. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.